Approval · Notice of Compliance 21448 · 2018
OCALIVA: Notice of Compliance 21448
Issued October 11, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21448
- Date
- October 11, 2018
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To revise the labelling
Products in this notice
Medicinal ingredients
- OBETICHOLIC ACID 5 MG per TAB
- OBETICHOLIC ACID 10 MG per TAB